Loading...
Market
What will be the main scientific challenge for Colossal Biosciences in thylacine de-extinction by end of 2025?
2
Resolution / Starting Odds
Genome editing accuracy • 25%
Embryo implantation success • 25%
Viability of living specimens • 25%
Public opposition or regulatory issues • 25%
Reports from Colossal Biosciences or scientific publications detailing challenges
Story
Colossal's 99.9% Accurate Thylacine Genome Marks Breakthrough in Tasmanian Tiger De-Extinction Effort
Oct 16, 2024, 08:32 PM
A team of US and Australian researchers has made significant breakthroughs in efforts to bring the Tasmanian tiger (thylacine) back from extinction. They have successfully sequenced the thylacine genome with 99.9% accuracy, a world-first achievement described as '99.9% of the puzzle.' This progress was made possible by a 'putrid' specimen found in a museum cupboard. The de-extinction company Colossal Biosciences claims multiple scientific firsts in this endeavor. While scientists welcome the advancement, they express caution and wish to see the data supporting these claims.
View original story
Similar markets
New genetic adaptation • 25%
Disease resistance genes • 25%
Cold environment adaptations • 25%
Other • 25%
Yes • 50%
No • 50%
Saber-toothed tiger • 25%
Dodo bird • 25%
Megalodon • 25%
Other • 25%
Evolution of amphibians • 25%
Jurassic ecosystems • 25%
Paleontological methods • 25%
Stem tetrapod lineage • 25%
Yes • 50%
No • 50%
Immune rejection • 25%
Infection risk • 25%
Ethical concerns • 25%
Supply chain issues • 25%
Cost • 25%
Efficiency • 25%
Regulation • 25%
Public acceptance • 25%
Ethical concerns • 25%
Regulatory hurdles • 25%
Environmental impact • 25%
Other • 25%
Scalability • 25%
Cost • 25%
Accuracy • 25%
Integration with existing systems • 25%
Improved gene editing techniques • 25%
New animal species used • 25%
Breakthrough in immunosuppressive drugs • 25%
Other significant advancement • 25%
AI-assisted analysis • 25%
Genetic analysis • 25%
Carbon dating • 25%
Other • 25%